Medtronic beat Q1 FY2027 estimates, raised guidance, and holds a Moderate Buy rating from analysts, with its 3%-plus dividend positioning it near Dividend King status.
Kedia exercised vested stock options at $55.01 per share and immediately sold them at $62.37, retaining a direct stake of 426,262 shares worth approximately $26.6 million.
Nebius has already proved demand. Now the real question is whether its massive AI backlog can become profitable capacity before spending, financing, and execution risk catch up.
Shares of Novavax are trading higher Tuesday. The stock is up over 30% over the trailing month as traders weigh updated autumn vaccine authorizations against the company's broader strategic pivot toward licensing and cost-structure optimization.
Oracle (NYSE:ORCL) has outperformed the market over the past 20 years by 2.3% on an annualized basis producing an average annual return of 11.54%. Currently, Oracle has a market capitalization of $406.81 billion.
U.S. employers will need a steady flow of accounting talent through the next decade. The Bureau of Labor Statistics projects about 124,200 openings for acc
Lumentum shares have surged about 140% in 2025 on AI optical demand, backed by strong earnings growth and a Moderate Buy rating with roughly 22% analyst upside.
